4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-000416
Pres and CEO gave up 9,125 shares (to pay taxes)
- Pres and CEO acquired 27,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Manion Douglas J. · Pres and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-01 | Exercise or conversion : show line 1 in the form | +27,000 | 50,938 | D | ||
| 2024-01-01 | Shares withheld for taxes : show line 2 in the form | −9,125 | $1.05 | $9,581 | 41,813 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −27,000 | 81,000 | D |
Loading xslF345X05/doc4.xml…